Name: Hypercalcemia Pathophysiology and Treatment (en Inglés)
Price: 1570.60 MXN
Availability: InStock
Author: Lumachi, Franco
ISBN: 9781608053582

Envío gratis

portada Hypercalcemia Pathophysiology and Treatment (en Inglés)

Formato

Libro Físico

Autor

Franco Lumachi

Editorial

Bentham Science Publishers

Idioma

Inglés

N° páginas

114

Encuadernación

Tapa Blanda

Dimensiones

27.9 x 21.6 x 0.8 cm

Peso

0.39 kg.

ISBN13

9781608053582

Categorías

El metabolismo
Endocrinología

Hypercalcemia Pathophysiology and Treatment (en Inglés)

Franco Lumachi (Autor) · Bentham Science Publishers · Tapa Blanda

Libro Nuevo

$ 1,570.60

$ 2,855.64

Ahorras: $ 1,285.04

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 05 de Agosto y el Viernes 16 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Hypercalcemia Pathophysiology and Treatment (en Inglés)"

Hypercalcemia is a relatively common disorder, which requires specific treatment in order to control symptoms and prevent the development of organ damage. Primary hyperparathyroidism and malignancy are responsible for most cases of hypercalcemia, and treatment has therefore been focused towards these two areas. The aim of this book is to present updated knowledge on hypercalcemia, its association with renal disorders, and benign and malignant diseases, diagnostic methodologies, as well as surgical and medical treatment. Insights into the etiology, pathogenesis and pathophysiology of hypercalcemia are included along with details on biochemical findings and ways to monitor complications and therapy. Suggestions on current imaging techniques and surgical treatment of hypercalcemia, are also presented. The book presents an overview on the pharmacology of anti-hypercalcemic drugs, also providing information on new drugs and future perspectives. The book will serve as a comprehensive reference source for oncologists, nephrologists, endocrinologists, clinicians, biochemists and pharmacologists, as well those involved in hypercalcemia management and research.